PHOEBE UNDERWOOD-DAVIS: Open Payments
NPI 1457844722 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 4 payments from 4 companies in 2025. Trend: 2023 $111 · 2024 $346 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: CAPLYTA, FANAPT, ABILIFY MAINTENA, COBENFY.
Industry payments across MD — which companies pay providers there.
